Kymera Therapeutics, Inc. · NASDAQ:KYMR

Mainolfi Nello sold 30,000 Kymera Therapeutics, Inc. shares (Form 4)

Traded Oct 1, 2026 · Filed Oct 1, 2026

On Oct 1, 2026, Mainolfi Nello (Director, Chief Executive Officer) sold 30,000 Kymera Therapeutics, Inc. shares at an average US$113.80 for US$3.41M under a trading plan, leaving 666,568 shares. Filed Oct 1, 2026 (Form 4).

Sold
30,000 shares
Price
US$113.80 average (US$111.44 to US$116.12)
Value
US$3.41M
Holding after
666,568 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 1, 2026Common StockOption exercise30,000US$2.08696,568Direct
Oct 1, 2026Common StockSale3,525US$111.44693,043Direct
Oct 1, 2026Common StockSale5,506US$112.42687,537Direct
Oct 1, 2026Common StockSale4,876US$113.24682,661Direct
Oct 1, 2026Common StockSale7,601US$114.43675,060Direct
Oct 1, 2026Common StockSale8,230US$115.40666,830Direct
Oct 1, 2026Common StockSale262US$116.12666,568Direct

Source

View original at SEC

Related